Evropa Lek Pharma D.O.O. Beograd is an enterprise in Serbia, with the main office in Belgrade. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The company was established on October 22, 2000. There are currently 80 (2024) people employed by Evropa Lek Pharma D.O.O. Beograd. There was a net sales revenue increase of 29.96% reported in Evropa Lek Pharma D.O.O. Beograd’s latest financial highlights for 2024. Its’ total assets recorded a growth of 11.25%. The net profit margin of Evropa Lek Pharma D.O.O. Beograd decreased by 6.21% in 2024.

Headquarters
Bore Stankovica 2
Belgrade; Belgrade;

Contact Details: Purchase the Evropa Lek Pharma D.O.O. Beograd report to view the information.

Website: http://www.elpharma.com

Basic Information

Total Employees:

Purchase the Evropa Lek Pharma D.O.O. Beograd report to view the information.

Registered Capital:

Purchase the Evropa Lek Pharma D.O.O. Beograd report to view the information.

Financial Auditors:

Purchase the Evropa Lek Pharma D.O.O. Beograd report to view the information.

Incorporation Date:

October 22, 2000

Key Executives

Purchase this report to view the information.

Director

Purchase this report to view the information.

Director

Purchase this report to view the information.

Representative

Ownership Details

Purchase this report to view the information.

100%

Subsidiaries

Phoenix It Services

100%

El Pharma D.O.O. (Bosnia and Herzegovina)

Evropa Lek Farma D.O.O.E.L. (North Macedonia)

Company Performance

Financial values in the chart are available after Evropa Lek Pharma D.O.O. Beograd report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.

Net sales revenue

29.96%▲

Total Operating Revenue

30.13%▲

Operating Profit

31.15%▲

EBITDA

27.89%▲

Net Profit/Loss for the Period

-37.38%▼

Total Assets

11.25%▲

Total Equity

6.64%▲

Operating Profit Margin

0.07%▲

Net Profit Margin

-6.21%▼

Return on Equity (ROE)

-14.78%▼

Debt / Equity

0.27%▲

Quick Ratio

-0.01%▼

Cash Ratio

-0.05%▼

Evropa Lek Pharma D.O.O. Beograd (Serbia)

Similar companies